Evidence map›Paper›PMID 21930586›Full record

ArticlePhilosophical transactions of the Royal Society of London. Series B, Biological sciences2011

Use of a coenzyme by the glmS ribozyme-riboswitch suggests primordial expansion of RNA chemistry by small molecules.

Adrian R Ferré-D'Amaré

Open access · bronzeAbstract read
In one paragraph

Article in Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Recent advances and future trends of riboswitches: attractive regulatory tools.World journal of microbiology & biotechnology · 2018
    Review
  4. Unwinding the twister ribozyme: from structure to mechanism.Wiley interdisciplinary reviews. RNA · 2017
    Review
  5. A divalent cation-dependent variant of theRNA (New York, N.Y.) · 2017
    Article
  6. Article
  7. Article
  8. Decoding mechanisms by which silent codon changes influence protein biogenesis and function.The international journal of biochemistry & cell biology · 2015
    Review
  9. Article
  10. Article
  11. Review
  12. The chemical origins of life and its early evolution: an introduction.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2011
    Article
  13. Structure and mechanism of the T-box riboswitches.Wiley interdisciplinary reviews. RNA
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Adrian R Ferré-D'AmaréLaboratory of RNA Biophysics and Cellular Physiology, National Heart, Lung and Blood Institute, 50 South Drive, MSC-8012, Bethesda, MD 20892-8012, USA. ferrea@mail.nih.gov
National Heart Lung and Blood Institute · US

Funding

RNA: New Antimicrobial StrategiesZIAHL006150 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI FERRÉ-D'AMARÉ, ADRIAN · 2012 to 2025
$11.8M
Intramural NIH HHS
6 · The paper itself

Abstract

The glmS ribozyme-riboswitch is the first known example of a naturally occurring catalytic RNA that employs a small molecule as a coenzyme. Binding of glucosamine-6-phosphate (GlcN6P) activates self-cleavage of the bacterial ribozyme, which is part of the mRNA encoding the metabolic enzyme GlcN6P-synthetase. Cleavage leads to negative feedback regulation. GlcN6P binds in the active site of the ribozyme, where its amine could function as a general acid and electrostatic catalyst. The ribozyme is pre-folded but inactive in the absence of GlcN6P, demonstrating it has evolved strict dependence on the exogenous small molecule. The ribozyme showcases the ability of RNA to co-opt non-covalently bound small molecules to expand its chemical repertoire. Analogue studies demonstrate that some molecules other than GlcN6P, such as l-serine (but not d-serine), can function as weak activators. This suggests how coenzyme use by RNA world ribozymes may have led to evolution of proteins. Primordial cofactor-dependent ribozymes may have evolved to bind their cofactors covalently. If amino acids were used as cofactors, this could have driven the evolution of RNA aminoacylation. The ability to make covalently bound peptide coenzymes may have further increased the fitness of such primordial ribozymes, providing a selective pressure for the invention of translation.

Indexed as

RiboswitchAllosteric SiteBacteriaBacterial ProteinsCatalysisCatalytic DomainCoenzymesEnzyme ActivationGlucosamineGlucose-6-PhosphateGlutamine-Fructose-6-Phosphate Transaminase (Isomerizing)RNARNA, CatalyticRNA CleavageRNA SplicingSubstrate SpecificityBacterial ProteinsCoenzymescomponent S, glutamate mutase protein, BacteriaGlucosamineglucosamine 6-phosphateGlucose-6-PhosphateGlutamine-Fructose-6-Phosphate Transaminase (Isomerizing)RiboswitchRNARNA, Catalytic

Identifiers

PMID21930586
PMCPMC3158913
OpenAlexW2081030386

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.